June 11, 2020 / 4:52 PM / a month ago

BRIEF-U.S. FDA Grants Approval Of Semglee (Insulin Glargine Injection) To Mylan

June 11 (Reuters) - FDA:

* FDA - APPROVES SEMGLEE TO IMPROVE GLYCEMIC CONTROL IN ADULTS, PEDIATRIC PATIENTS WITH TYPE 1 DIABETES MELLITUS, IN ADULTS WITH TYPE 2 DIABETES MELLITUS

* FDA - GRANTS APPROVAL OF SEMGLEE (INSULIN GLARGINE INJECTION) TO MYLAN PHARMACEUTICALS, INC

* FDA - SEMGLEE IS CONTRAINDICATED DURING EPISODES OF HYPOGLYCEMIA & IN PATIENTS WITH HYPERSENSITIVITY TO INSULIN GLARGINE OR ITS EXCIPIENTS Source text: (bit.ly/2Yr3akz) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below